Twitter
RSS
Facebook

Biotechnology & Medical Investors Database

Investments have continued to flow into medical sectors this year, as ageing population and growing number of diseases have helped both biotechnology & pharmaceutical companies to maintain growth. The investments have been quite diversified, a lot of investments have been invested into discovery of new drug developments, while medical devices continue to attract new capital from investment firms worldwide. Another 2 shining areas are E-health and diagnostic markets. There are also companies that have raised capital for acquisitions and expanding their global portfolio.

In terms of venture capital & private equity investors, there have been large transactions both from major biotech markets such as USA, UK, Germany, Japan and Switzerland while emerging investment markets led by Chinese, Indian, Israeli as well as Australian and Canadian investors have also injected new investment capital into the ever growing medical markets.

Our Global Biotechnology Capital Providers Guide provides an extensive database of over 1,000 investment firms that are active in all types of medical related industries – these include investors from Americas, Asia and European regions.

Please write to ceo@hindmarshfinance.com for more details about obtaining your Global Biotechnology Capital Providers Guide.